PFE Stock 12 Month Forecast $31.56 ▲(24.99% Upside) Based on19Wall Street analysts offering 12 month price targets forPfizerin the last3 months. The average price target is$31.56with a high forecast of$45.00and a low forecast of$25.00. The average price target represents a24.99%change from...
said they're unhappy with how the company handled cost cuts in 2023. Some alleged that Pfizer management provided little transparency around the layoffs and seemed more focused on the company's stock performance than its staff throughout the process. ...
Pfizer (PFE) adaptive stock price forecast & ideologically balanced news. Transparently evaluate AI model performance.
Equities PFE US7170811035 Pharmaceuticals Market Closed -Nyse 04:00:02 2025-03-17 pm EDTAfter market07:35:27 pm 26.05USD+1.28% 26.10+0.21% Mar. 17Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care RoundupDJ ...
Looking ahead, the New York-based company maintained its 2023 sales forecast of $67 billion to $71 billion. Pfizer also reiterated its full-year adjusted earnings outlook of $3.25 to $3.45 per share. But Pfizer continues to expect Covid-related sales to decline this year. The company reaffir...
Now, we feel comfortable to forecast it and we have seen strong growth from the remaining part of the business. We have seen strong performance from new products. Most of them, they have beaten analyst expectations this quarter, which shows that they are doing better at me than what was pe...
That represents a premium of nearly 43% from the stock's closing price of $47.99 on Aug. 4, the day before The Wall Street Journal reported that Pfizer was in advanced talks on a deal. Both companies' boards have approved the deal, which still needs regulatory approval and approval from ...
Pfizer Inc. reported financial results for the first quarter of 2024 and raised its Adjusted diluted EPS guidance while maintaining all other components of its 2024 financial guidance.
Seagen stock is trading around $192, a hefty discount from Pfizer’s buy price of $229 per share. If closed, the deal is expected to contribute over $10 billion in sales for Pfizer by 2030. Kate Goodwin is a freelance life science writer based in Des Moines, Iowa. She c...
price of Pfizer’s common stock and/or operating results; significant transaction costs; unknown liabilities; the risk of litigation and/or regulatory actions related to the proposed acquisition or Seagen’s business; risks related to the financing of the transaction; other business effects and ...